cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Lianbio
Current Price
$2.25
$0.01
(0.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
243.8M
52-Week High
52-Week High
6.24
52-Week Low
52-Week Low
1.07
Average Volume
Average Volume
0.05M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization243.8M
icon52-Week High6.24
icon52-Week Low1.07
iconAverage Volume0.05M
iconDividend Yield--
iconP/E Ratio--
What does the Lianbio do?
LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex blepharitis; NBTXR3 for the treatment of head and neck squamous cell carcinoma, and solid tumor; Infigratinib for the treatment of second-line and first-line cholangiocarcinoma, and gastric cancers; BBP-398 for solid tumors; Omilancor for ulcerative colitis and Crohn s disease; NX-13 for ulcerative colitis; LYR-210 for chronic rhinosinusitis; and Sisunatovir for respiratory syncytical virus. It has a partnership with Tarsus Pharmaceuticals, Inc. to develop and commercialize TP-03, an eye solution for the treatment of Demodex blepharitis; and Nanobiotix S.A. to develop and commercialize NBTXR3, a radioenhancer designed to be injected directly into a malignant tumor prior to standard radiotherapy. The company was incorporated in 2019 and is headquartered in Princeton, New Jersey.
Read More
How much money does Lianbio make?
News & Events about Lianbio.
Globe Newswire
3 months ago
SHANGHAI, China and PRINCETON, N.J., Nov. 10, 2022 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that members of the management team will participate in the following ...
Zolmax
3 months ago
I-Mab (NASDAQ:IMAB Get Rating) and LianBio (NASDAQ:LIAN Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, dividends, institutional ownership, earnings, analyst recommendations, profitability and ...
Ticker Report
8 months ago
LianBio (NASDAQ:LIAN Get Rating) Director Perceptive Advisors Llc acquired 120,000 shares of the firms stock in a transaction that occurred on Wednesday, May 25th. The shares were purchased at an average cost of $2.63 per share, for a total transaction of $315,600.00. Following the ...
PR Newswire
8 months ago
Thinking about buying stock in LianBio, BioSig Technologies, Nordstrom, Apyx Medical, or Bloomin' Brands? Thinking about buying stock in LianBio, BioSig Technologies, Nordstrom, Apyx Medical, or Bloomin' Brands? PR Newswire NEW YORK, May 26, 2022 NEW YORK, May 26, 2022 /PRNewswire...
Globe Newswire
9 months ago
LianBios partner, Bristol Myers Squibb, has received U.S. FDA approval of mavacamten for the treatment of patients with obstructive hypertrophic cardiomyopathy (oHCM) Registrational Phase 3 EXPLORER-CN clinical trial of mavacamten in Chinese patients with symptomatic oHCM ongoingLianBios partner, ...
Frequently Asked Questions
Frequently Asked Questions
What is Lianbio share price today?
plus_minus_icon
Can Indians buy Lianbio shares?
plus_minus_icon
How can I buy Lianbio shares from India?
plus_minus_icon
Can Fractional shares of Lianbio be purchased?
plus_minus_icon
What are the documents required to start investing in Lianbio stocks?
plus_minus_icon
What is today’s traded volume of Lianbio?
plus_minus_icon
What is today’s market capitalisation of Lianbio?
plus_minus_icon
What is the 52-Week High and Low Range of Lianbio?
plus_minus_icon
What percentage is Lianbio down from its 52-Week High?
plus_minus_icon
What percentage is Lianbio up from its 52-Week Low?
plus_minus_icon
Current Price
$2.25
$0.01
(0.45%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00